Bookmark

Address

Shire PLC
5 Riverwalk
Citywest Business Campus
Dublin
Co. Dublin
Ireland

Open map

Website
http://www.shire.com
Sector
Biotech and Healthcare

Recent investment activity


Search trends
Patents
KANDO id: 14395711

Corporate information

Official name
Shire PLC

Overview

Shire enables people with life-altering conditions to lead better lives. Shire's strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. Shire's focus is on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.



Funding rounds

Acquisition

( )

Profile Country Notes
Takeda Pharmaceutical Co Ltd Initial investment.

Acquisition USD 54,800,000,000

USD 54,800,000,000 ( ) at USD 54,800,000,000 pre-money valuation
ABANDONED

Profile Country Notes
Abbvie Inc
United States
 USD 54,800,000,000 (USD 54,800,000,000) Initial investment.

N/A


Profile Country
Blue Chip Venture Co
United States

N/A


Profile Country
Essex Woodlands Health Ventures Inc
United States

Actual initial investment stage
Acquisition (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Date Funding
ViroPharma Inc Provider of life-saving medicines for life-threatening diseases.
United States
 Acquisition Initial investment led the round USD 4,200,000,000 (USD 4,200,000,000)

Current team

Past employees

Selected Products / Customers

Financials